NCT01804634View on ClinicalTrials.gov

Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 27, 2013

Primary Completion Date

January 31, 2027

Study Completion Date

January 31, 2030

Conditions
Refractory and/or Relapsed Metastatic Solid Tumors
Interventions
DRUG

Cyclophosphamide

preparative regimen

DRUG

Fludarabine

RADIATION

low dose total body irradiation

DRUG

Melphalan

DRUG

Tacrolimus

Trial Locations (4)

10467

RECRUITING

Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx

10595

RECRUITING

New York Medical Center/ Maria Fareri Children's Hospital, Valhalla

21231

RECRUITING

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

33701

ACTIVE_NOT_RECRUITING

Johns Hopkins All Children's Hospital, St. Petersburg

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER